CYCS and acute kidney injury: Another possibility for the treatment of AKI is using the terapeptide SS-31 Szeto-Sciller peptide or Bendavia because it stabilizes cardiolipin by controlling the activity of Cytochrome C (cyt C) and inhibiting the mitochondrial permeability transition (mPT), which improves kidney perfusion.